Valneva SE ADR 58.64 USD
#1
Information 

Valneva SE ADR

58.64 USD
Reply
#2

We are extremely pleased that the European Commission and the Member States have completed this purchase agreement and are eager to help address the ongoing pandemic.

We continue to receive messages from people across the world requesting access to an inactivated vaccine.

Our Phase 3 results confirmed the advantages often associated with inactivated vaccines and we continue to believe that our differentiated vaccine candidate can make an important contribution to the global fight against the COVID-19 pandemic.

https://valneva.com/press-release/valnev...e-vla2001/
Reply


Forum Jump:


Users browsing this thread: 2 Guest(s)